Pyruvate kinase deficiency in 29 Turkish patients with two novel intronic variants

Br J Haematol. 2024 Jul;205(1):236-242. doi: 10.1111/bjh.19575. Epub 2024 May 29.

Abstract

Pyruvate kinase (PK) is a key enzyme of anaerobic glycolysis. The genetic heterogeneity of PK deficiency (PKD) is high, and over 400 unique variants have been identified. Twenty-nine patients who had been diagnosed as PKD genetically in seven distinct paediatric haematology departments were evaluated. Fifteen of 23 patients (65.2%) had low PK levels. The PK:hexokinase ratio had 100% sensitivity for PKD diagnosis, superior to PK enzyme assay. Two novel intronic variants (c.695-1G>A and c.694+43C>T) have been described. PKD should be suspected in patients with chronic non-spherocytic haemolytic anaemia, even if enzyme levels are falsely normal. Total PKLR gene sequencing is necessary for the characterization of patients with PKD and for genetic counselling.

Keywords: PKD; PKLR; enzyme; haemolytic anaemia; pyruvate kinase.

MeSH terms

  • Adolescent
  • Anemia, Hemolytic, Congenital Nonspherocytic* / genetics
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Introns*
  • Male
  • Mutation
  • Pyruvate Kinase* / deficiency
  • Pyruvate Kinase* / genetics
  • Pyruvate Metabolism, Inborn Errors* / genetics
  • Turkey

Substances

  • Pyruvate Kinase
  • PKLR protein, human

Supplementary concepts

  • Pyruvate Kinase Deficiency of Red Cells